Pfizer-BioNTech COVID-19 Vaccine Safe, Effective in Cancer Patients
Pronounced lag in antibody production after the first dose found versus noncancer controls
Neither Remdesivir Nor HCQ Affect Viral Clearance in COVID-19
No significant difference seen for in-hospital mortality among those receiving remdesivir, hydroxychloroquine, standard of care
Burnout Symptoms Present in More Than One in Four Cardiologists
Leading cardiology associations identify drivers associated with burnout, including lack of control over workload, hectic work environment
Disparities in Breast Cancer Survival Persist for Black Women
Although nearly all metrics improved for racial-ethnic minorities, recent breast cancer-related mortality in Florida still higher in Black women
Athletes Have Higher Risk for Developing Atrial Fibrillation
Risk greater in athletes younger than 55 years and among those participating in mixed sport versus endurance sport
High-Efficacy Therapy May Reduce Relapses in Active SPMS
But no difference in disability progression seen for high-efficacy versus low-efficacy therapy for secondary progressive multiple sclerosis
Pfizer to Meet With U.S. Officials About COVID-19 Booster Shot
Pfizer cited data from Israel showing the vaccine is declining in effectiveness as the highly contagious Delta variant circulates
FDA Head Asks for Investigation Into Alzheimer Disease Drug Approval
Request follows reports that Biogen and the FDA held off-the-books meetings before the drug's approval that may have violated FDA protocol
WHO Calls for Global Registry of Human Genome Editing
Studies involving human genome editing should be made public, even though it would not necessarily stop unprincipled scientists
Cardiovascular Drugs Do Not Impact COVID-19 Outcomes
Authors say patients even with COVID-19 should continue taking cardiovascular drugs as prescribed
